HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Clinical trials for HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a text message save a life? new study aims to keep breast cancer patients on track
Disease control OngoingThis study is testing whether simple support tools can help breast cancer patients remember to take their daily hormone therapy pills correctly. Researchers are comparing text message reminders, phone-based counseling sessions, or both, against standard care to see which method w…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug combo tested for Tough-to-Treat breast cancer
Disease control OngoingThis study is testing whether adding the drug alpelisib to standard hormone therapy can help control advanced breast cancer that has a specific genetic change (PIK3CA mutation) and has stopped responding to hormone therapy alone. It will involve about 44 adults with this type of …
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Marina N Sharifi • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New weapon against cancer enters human testing
Disease control OngoingThis is an early-stage study testing a new antibody drug called IMT-009 in people with advanced solid tumors or lymphomas that have stopped responding to standard treatments. The main goals are to find a safe dose, understand the side effects, and see if the drug helps shrink tum…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Immunitas Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New scan aims to spot if breast cancer treatment is working sooner
Diagnosis OngoingThis study is testing whether a special type of PET/CT scan can better measure how well treatment is working for breast cancer that has spread to the bones. About 138 patients with this type of advanced cancer will get the scan before starting treatment and again 12 weeks later. …
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC